MetaMe Health develops FDA-cleared prescription digital therapeutics that utilize software applications to train the brain for managing gastrointestinal conditions. This approach provides patients with a non-pharmacological option to alleviate chronic pain and improve their quality of life through accessible mobile technology.
Funding
$7.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals experience chronic gastrointestinal (GI) conditions that significantly impact their quality of life and often require ongoing management. Traditional treatment approaches may not always provide sufficient relief, and patients seek alternative, non-pharmacological options to alleviate their symptoms.
Solution
MetaMe Health develops prescription digital therapeutics (PDTs) delivered through mobile applications, offering a novel approach to managing GI disorders. These software applications are designed to train the brain to better regulate the body's response to chronic conditions, providing patients with a convenient and accessible tool for symptom management. By leveraging the principles of neuroplasticity, MetaMe Health's PDTs empower individuals to take control of their health and improve their overall well-being through targeted cognitive exercises and behavioral interventions. The mobile delivery ensures accessibility and allows patients to engage with the therapy in the comfort of their own homes.
Target Audience
The primary target audience includes individuals diagnosed with chronic gastrointestinal conditions seeking non-pharmacological treatment options, as well as healthcare providers looking to expand their therapeutic toolkit with innovative digital solutions.
Features
- FDA-cleared prescription digital therapeutics for managing gastrointestinal conditions
- Mobile application-based delivery for convenient access and engagement
- Cognitive training exercises designed to modulate brain activity and reduce symptom severity
- Personalized treatment plans tailored to individual patient needs
- Progress tracking and monitoring to assess treatment effectiveness